Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook

The veterinary active pharmaceutical ingredients manufacturing market in Asia Pacific is expected to reach a projected revenue of US$ 3,888.3 million by 2030. A compound annual growth rate of 7.8% is expected of Asia Pacific veterinary active pharmaceutical ingredients manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,303.5
Forecast, 2030 (US$M)
$3,888.3
CAGR, 2024 - 2030
7.8%
Report Coverage
Asia Pacific

Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific veterinary active pharmaceutical ingredients manufacturing market highlights

  • The Asia Pacific veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 2,303.5 million in 2023.
  • The market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
  • In terms of segment, in house was the largest revenue generating service type in 2023.
  • Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 2,303.5 million
Market revenue in 2030USD 3,888.3 million
Growth rate7.8% (CAGR from 2023 to 2030)
Largest segmentIn house
Fastest growing segmentContract Outsourcing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIn House, Contract Outsourcing
Key market players worldwideZoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 26.6% of the global veterinary active pharmaceutical ingredients manufacturing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,888.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies

Name Profile # Employees HQ Website

Asia Pacific veterinary active pharmaceutical ingredients manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.


In house was the largest segment with a revenue share of 63.38% in 2023. Horizon Databook has segmented the Asia Pacific veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.


The veterinary API manufacturing market in Asia Pacific is expected to grow at a lucrative rate over the forecast period. The market is driven by high investments in R&D by global players and consistent efforts to commercialize veterinary pharmaceuticals at relatively low prices.

In addition, the need to curb the high prevalence of zoonotic disease and manage disease outbreaks, such as swine influenza and Ebola, is expected to propel market growth over the forthcoming decade.Growth in the region can also be attributed to a significantly high cattle population.

According to the report published by the U.S. Department of Agriculture (USDA), in 2023, China and India constitute over 43% of the global cattle population. Furthermore, rising disposable income increases the chances of adopting companion animals, creating future growth opportunities.

Reasons to subscribe to Asia Pacific veterinary active pharmaceutical ingredients manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific veterinary active pharmaceutical ingredients manufacturing market databook

  • Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific veterinary active pharmaceutical ingredients manufacturing market size, by country, 2018-2030 (US$M)

Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific veterinary active pharmaceutical ingredients manufacturing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more